MedTrace Logo

Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment

NCT02539940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2020-03-10

No results posted yet for this study

Summary

The aim of this observational study is to evaluate the outcomes and safety of the Paclitaxel-eluted balloon catheter ELUTAX SV for treatment of peripheral arterial disease (PAD) in below-the-knee vessels

Conditions

Interventions

DEVICE

Angioplasty Paclitaxel-eluted balloon catheter ELUTAX SV

Angioplasty for revascularization in below-the-knee arteries

Sponsors & Collaborators

  • Zentrum für Klinische Studien Jena

    collaborator OTHER

  • Aachen Resonance GmbH

    collaborator INDUSTRY

  • Jena University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-04-30
Completion
2018-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02539940 on ClinicalTrials.gov